What is Lifecore Biomedical, Inc.'s debt-to-assets?

Lifecore Biomedical, Inc. (LFCR) reported debt-to-assets of 0.7× in Q1 2026.

How has Lifecore Biomedical, Inc.'s debt-to-assets changed year-over-year?

Lifecore Biomedical, Inc.'s debt-to-assets increased by 1396.6% year-over-year, from 0× to 0.7×.

What is the long-term trend for Lifecore Biomedical, Inc.'s debt-to-assets?

Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s debt-to-assets has grown at a 12.7% compound annual growth rate (CAGR), from 0.4× to 0.7×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Lifecore Biomedical, Inc. LFCR Debt-to-assets

Debt-to-assets at other companies

Baxter InternationalBAX

0×0.0×

Thermo Fisher ScientificTMO

0.4×0.0×

ADMA BiologicsADMA

0.3×+0.3×

Medpace Holdings, Inc.MEDP

0.1×0.0×

Biodesix, Inc.BDSX

0.8×0.0×

ClearPoint NeuroCLPT

0.7×+0.6×

Other financials

Income statement

See full

Revenue$23.2M-36.4%

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

Operating cash flow$4.7M—

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation

See full

Market cap$196.92M-35.4%

Enterprise value$333.06M+8.3%

P/S1.6×+0.5×

Profitability

See full

Gross margin31.3%-1.4pp

Operating margin-14.5%-2.2pp

Net margin-30%—

FCF margin-36.4%—

Returns & leverage

See full

Return on equity-612.1%—

Debt / equity8.3×-1.5×

Current ratio3.8×+0.9×

Where this comes from

Calculated from Lifecore Biomedical, Inc.’s reported figures.

total debt/total assets=0.7×

Based on the most recent quarter.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s debt-to-assets?: Lifecore Biomedical, Inc. (LFCR) reported debt-to-assets of 0.7× in Q1 2026.
How has Lifecore Biomedical, Inc.'s debt-to-assets changed year-over-year?: Lifecore Biomedical, Inc.'s debt-to-assets increased by 1396.6% year-over-year, from 0× to 0.7×.
What is the long-term trend for Lifecore Biomedical, Inc.'s debt-to-assets?: Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s debt-to-assets has grown at a 12.7% compound annual growth rate (CAGR), from 0.4× to 0.7×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.